Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting ODC can prevent UV-induced skin cancer.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Mobile phone radiation can cause DNA damage in human hair root cells.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

COVID-19 infection may trigger alopecia areata in some patients.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.